The Cardiovascular Atherosclerosis: Prediction, Prevention and Management provides new medications and clinical data pertaining to the management and treatment of atherosclerosis.
The Cardiovascular Atherosclerosis: Prediction, Prevention and Management covers topics such as:
- Mechanism and indication of PCSK9 inhibitors and omega 3 fish oil
- Cardiac risk factors and estimation of patients clinical risk
- The cardiovascular benefits associated with diet and exercise modifications
- Mechanism and indication of SGL2 inhibitors as well as GLP1 agonists mechanisms of action and cite indications for use
- Polygenetic risk scoring in primary prevention of atherosclerotic cardiovascular disease
- Cardiac CT scoring and utility of coronary CTA
The Cardiovascular Atherosclerosis: Prediction, Prevention and Management might be held in California, United States in May 2025.
